Breath Test Symptoms Help Predict Lactose Intolerance in Adults

Authors
Journal
Clinical Nutrition ESPEN
Year
DOI
10.1016/j.clnesp.2025.11.151
Study Type
Human
Outcome
Positive
Peer Reviewed
Yes
Country
Italy
Health Condition
Lactose Intolerance
Body System
Digestive

TL;DR

Flatulence during lactose breath testing strongly predicts lactose malabsorption, and adding methane measurement improves diagnostic accuracy.

Key Finding

Flatulence experienced during lactose breath testing was the strongest symptom predictor of lactose malabsorption, and people with severe symptoms (rated 6 or higher on a pain scale) were significantly more likely to be malabsorbers than those with mild symptoms.

Summary

This study looked at whether symptoms people experience during a lactose breath test (a test that measures gases produced when the body can't digest lactose) can predict lactose malabsorption—when the body struggles to break down lactose, a sugar in milk. Researchers tested 199 adults and found that flatulence (gas) during the test was the best symptom for predicting malabsorption, and people who experienced severe symptoms were more likely to be malabsorbers. The study also found that measuring methane gas in addition to hydrogen gas improved the accuracy of the test.

Practical Takeaway

If you're being tested for lactose malabsorption, paying attention to which symptoms you experience during the test—especially gas—may help doctors better understand your results. This study suggests that a more complete testing approach that measures both hydrogen and methane gases, combined with careful symptom tracking, may provide more accurate diagnosis than hydrogen measurement alone, potentially helping avoid unnecessarily strict dairy avoidance. However, this is a single study in adults with existing digestive symptoms, so results may not apply to everyone.

Abstract

Background/objective: Lactose malabsorption (LM) is common, yet not all malabsorbers develop lactose intolerance (LI). We aimed to assess whether symptoms recorded during the hydrogen breath test (HBT) predict LM and whether methane (CH4) measurement adds diagnostic information. Methods: In this retrospective study, 199 adults without organic gastrointestinal disease underwent a standardized lactose HBT between January 2022 and February 2025). Pre-test and intra-test gastrointestinal symptoms were graded on a 0-10 Numerical Rating Scale (NRS) and used to classify LI as mild, moderate, or severe. LM was defined by a ≥ 20 ppm rise in H2 from baseline; CH4 positivity by a ≥ 10 ppm rise. Univariable and multivariable analyses explored the association between symptoms and test outcomes. Results: LM was present in 56,8% of patients. Overall, 84.9% reported at least one symptom during the test. Flatulence during testing was the symptom most strongly associated with LM (p < 0,01) and correlated with peak H2 values, whereas pre-test symptoms showed no association with LM. Patients who experienced at least one severe symptom (NRS ≥6) were significantly more likely to be malabsorbers (39,8% vs 18,6%; p = 0,002), while lower symptom grades were frequent in both LM+ and LM- subjects. CH4 positivity was observed in 19,1% of patients; in 3,5% of the cohort, LM was detected only by CH4 despite a negative HBT. Higher baseline CH4 anticipated a greater post-challenge increase. Conclusions: In adults with unexplained functional gastrointestinal symptoms, standardized symptom recording during lactose breath testing provides clinically useful context, with flatulence emerging as the most informative symptom for LM. Grading intolerance according to symptom severity effectively helps to identify lactose malabsorbers. Adding methane measurements may further improve diagnostic accuracy. Overall, these findings support an individualized diagnostic pathway that blends gas profiling with standardized symptom scoring-guiding targeted management while limiting unnecessarily restrictive diets.